February 26, 2013 — TeraMedica debuted the Evercore Connext Mobile at the 2013 HIMSS conference, bringing groundbreaking, seamless point-of-care data capture and archiving to an iPad or iPhone. At the touch of a button, Evercore Connext Mobile acquires photos, videos, sound files, notes and more with the highest level of security. Data is automatically archived directly to the hospital’s Evercore VNA as an integral part of the patient record for viewing through an electronic medical record (EMR) and the integrated TeraMedica Univision viewer.

 

The TIMS Medical division of Foresight Imaging released the TIMS version 3.0 platform to provide high resolution digital video formats in fluoroscopy and endoscopy.

Medtronic Inc. announced it received U.S. Food and Drug Administration (FDA) approval to conduct an early feasibility study using the Medtronic Native Outflow Tract Transcatheter Pulmonary Valve (TPV). This approval represents the first-ever FDA approval of an investigational device exemption (IDE) following the new draft FDA guidance for early feasibility studies.


The U.S. Food and Drug Administration (FDA) has approved the 34 and 38 mm lengths of the Medtronic Resolute Integrity drug-eluting stent in diameters of 3, 3.5 and 4 mm with an indication for patients with diabetes.


New research at Saint Louis University shows physicians do not talk to patients about the psychosocial impact and long-term risks of implanting cardioverter defibrillators (ICDs) to treat irregular heart rhythms, leaving them misinformed about how the device may affect quality of life.



Taking a leadership role in addressing inefficient practices and improving care, the American Society of Echocardiography (ASE) has released a list of five interventions whose appropriateness physicians and patients should discuss as part of Choosing Wisely.



The White House’s recent approval of the Physician Payment Sunshine Act mandates transparency within physician-industry relationships. Data recording begins Aug. 1, 2013, so it is necessary for physicians and administrators to understand the implications of this section of the Affordable Care Act.


The American Heart Association (AHA) is focusing its advocacy efforts across the Midwest on the use of pulse oximetry screening (pulse ox) to detect congenital heart defects in newborns.

Subscribe Now